TLS/FUS (2meArg216 (asymetric)), (2meArg218 (asymetric)) Antikörper
-
- Target
- TLS/FUS
- Bindungsspezifität
- 2meArg216 (asymetric), 2meArg218 (asymetric)
- Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Unkonjugiert
- Applikation
- Immunoprecipitation (IP), Western Blotting (WB)
- Spezifität
- This antibody recognizes asymmetric dimethylarginine (R216, R218) of TLS/FUS. It does not cross-reacts against symmetric dimethylarginine of TLS/FUS, and non -methylated TLS /FUS. TLS: Translocated in LipoSarcoma FUS: Fused in Sarcoma
- Kreuzreaktivität
- Hamster, Human, Maus
- Kreuzreaktivität (Details)
- This antibody recognizes asymmetric dimethylarginine (R216, R218) of TLS/FUS. It does not cross-react against symmetric dimethylarginine of TLS/FUS, and non -methylated TLS /FUS.
- Produktmerkmale
-
Asymmetric Dimethylarginine of TLS/FUS (R216, R218)
Arginine methylation is one of posttranslational modifications. Arginine can be methylated onece (monomethylated arginine) or twice (dimethylated arginine). - Aufreinigung
- Protein G Purified
- Immunogen
- Synthetic CGGR me2a GR me2a GGSG
- Klon
- 2B12
- Isotyp
- IgG
-
-
- Applikationshinweise
- WB: 1: 500-1: 2000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0.5 mg/mL
- Buffer
- PBS, pH 7.2
- Lagerung
- -20 °C
-
- Target
- TLS/FUS
-